The case in front of me: hydrolysis · retatrutide · VendorInvestigate.
I would like to understand the steps well enough to explain them to someone else.
I have access to a refrigerator with a logger and a freezer without one, which may be relevant.
Concretely, what should I do, and how would I know afterwards whether I did it right?
The short version: intact crimp, seated stopper, legible lot code, and a cake that looks like a cake.
Look for fibres, glass fragments and dark particulate in the cake. Glass is the one that matters and is usually a crimping or handling artefact rather than a synthesis one.
| Vial | Diluent | Concentration | 0.25 mg | 0.5 mg | 1 mg | 2.5 mg |
|---|---|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 5 mg | 2 mL | 2.5 mg/mL | 10 u | 20 u | 40 u | 100 u |
| 10 mg | 1 mL | 10 mg/mL | 2.5 u | 5 u | 10 u | 25 u |
| 10 mg | 2 mL | 5 mg/mL | 5 u | 10 u | 20 u | 50 u |
| 10 mg | 3 mL | 3.33 mg/mL | 7.5 u | 15 u | 30 u | 75 u |
Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.
Melt-back at the stopper — a glassy ring where the cake meets the closure — indicates the cycle ran warm at the top of the vial. Cosmetic in most cases, informative always.
Visual inspection for particulate matter is a pharmacopoeial requirement for parenteral products and the standard technique uses both light and dark backgrounds.
Passing inspection is a weak result. It rules out the obvious and nothing else.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsTo be exact about it, this is a two-minute procedure that resolves a large fraction of the questions people ask afterwards.
Check the aluminium crimp is fully seated with no lift at the edge, the flip-off cap has not been previously removed, and the stopper sits flush without a visible gap or dimple.
Confirm the lot code is physically on the vial and legible, and that it matches the certificate and the invoice. A code on the box only ties a certificate to a box.
Melt-back and collapse are documented lyophilisation cycle defects with well-described visual appearances.
Crimp, stopper, label, contents. Light background and dark background.
Answer first: inspect before you reconstitute, because after reconstitution you cannot distinguish a particle that arrived with the powder from one you introduced.
After reconstitution, hold against a light and look for haze, floaters or a Tyndall effect. A clear solution that goes clear on contact is what a well-made preparation looks like.
Weigh the vial if you have a scale reading to a milligram. It will not give you content, but a vial several tens of milligrams lighter than its siblings is a fill problem.
Container closure integrity depends on the crimp and stopper seating, which is why those are the first things checked in any incoming-goods inspection.
A vial that passes inspection has passed a very weak test. It has not been verified.
Inspect before reconstitution. Afterwards you cannot tell whose particle it is.
edited 11 Jun 2026 by p_mkhize — corrected a unit error in the worked example
The relevant principle is that anything you find before reconstitution is the supplier's, and anything you find after might be yours.
Check the fill looks proportionate to the label claim. Ten milligrams of peptide is a small volume of powder, but it is not nothing, and a vial that looks empty is worth a photograph.
Lot traceability to the primary container rather than to secondary packaging is a basic requirement of any documentation system worth the name.
Do not open a vial you intend to return or claim on; photograph it sealed first.
The lot code has to be on the vial. A code on the box ties nothing to anything.
Answering this needs to know what you are looking for, because most people inspect vials without a list and therefore see nothing.
Inspect the powder against both a white and a black background under good light. Discolouration, browning or a yellow tinge on a peptide that should be white is worth photographing before doing anything else.
The general principle here — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science, and it is why licensed presentations contain a surfactant such as polysorbate 20 or 80. A research vial does not, which is precisely why handling matters more, not less.
The caveat is that inspection cannot detect identity, purity, content or endotoxin, which are the things most likely to be wrong.
Photograph anything unexpected before touching it further.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.